-There is increasing evidence that the metabolic state of the mother during pregnancy affects long-term glucose and lipid metabolism of the offspring. The liver X receptors (LXR)␣ and -␤ are key regulators of cholesterol, fatty acid, and glucose metabolism. LXRs are activated by oxysterols and expressed in fetal mouse liver from day 10 of gestation onward. In the present study, we aimed to elucidate whether in utero pharmacological activation of LXR would influence fetal fatty acid and glucose metabolism and whether this would affect lipid homeostasis at adult age. Exposure of pregnant mice to the synthetic LXR agonist T0901317 increased hepatic mRNA expression levels of Lxr target genes and hepatic and plasma triglyceride levels in fetuses and dams. T0901317 treatment increased absolute de novo synthesis and chain elongation of hepatic oleic acid in dams and fetuses. T0901317 exposure in utero influenced lipid metabolism in adulthood in a sex-specific manner; hepatic triglyceride content was increased (ϩ45%) in male offspring and decreased in female offspring (Ϫ42%) when they were fed a regular chow diet compared with untreated sex controls. Plasma and hepatic lipid contents and hepatic gene expression patterns in adult male or female mice fed a high-fat diet were not affected by T0901317 pretreatment. We conclude that LXR treatment of pregnant mice induces immediate effects on lipid metabolism in dams and fetuses. Despite the profound changes during fetal life, long-term effects appeared to be rather mild and sex selective without modulating the lipid response to a high-fat diet. fetus; lipid metabolism; gestation; long-term effects IN HUMANS, THE NUTRITIONAL CONDITION during pregnancy has been shown to have a persistent effect on aspects of lipid and carbohydrate metabolism of the developing fetus. Maternal overnutrition leads to a higher incidence of insulin resistance, obesity, hypertension, and cardiovascular diseases in adult offspring (6). Effects of a high-fat maternal diet during pregnancy on long-term health status of the offspring are relatively well studied in animal models (3). However, relatively little is known about long-term consequences of targeted alterations in fetal lipid metabolism in utero.
IN HUMANS, THE NUTRITIONAL CONDITION during pregnancy has been shown to have a persistent effect on aspects of lipid and carbohydrate metabolism of the developing fetus. Maternal overnutrition leads to a higher incidence of insulin resistance, obesity, hypertension, and cardiovascular diseases in adult offspring (6) . Effects of a high-fat maternal diet during pregnancy on long-term health status of the offspring are relatively well studied in animal models (3) . However, relatively little is known about long-term consequences of targeted alterations in fetal lipid metabolism in utero.
The liver X receptors (LXR) have been identified as key players in the regulation of cholesterol, fatty acid, and carbohydrate metabolism in adult mammals. LXR␣ (NR1H3) and LXR␤ (NR1H2) are members of the nuclear receptor superfamily of ligand-activated receptors. Both LXR isoforms are activated by oxidized cholesterol metabolites (oxysterols), with no LXR␣/␤ specificity documented (19) . Expression of LXR␣ is restricted mainly to liver, intestine, adipose tissue, and macrophages, whereas LXR␤ is broadly expressed (22) . Activated LXRs heterodimerize with ligand-activated retinoid X receptor (RXR) at LXR response elements present in the promotors of target genes to induce their transcription. Activation of LXRs induces expression of the sterol regulatory element-binding protein-1c (SREBP1c) that subsequently activates the lipogenic genes acetyl-CoA carboxylase (ACC), fatty acid synthase (FASN), and stearoyl-CoA desaturase 1 (SCD1) (28) . It has been postulated that activation of LXR could induce carbohydrate response element-binding protein (ChREBP) and in this way indirectly influence glycolysis via influencing expression of liver-specific pyruvate kinase (PKLR) (7) .
Expression of Lxra and Lxrb has been demonstrated in mouse fetuses from day 11.5 postcoitum onward (2) ; however, the functional role of LXRs during fetal development and in the newborn has not been defined. LXR does not appear to be essential for normal fetal development, because mice with targeted inactivation of Lxra, Lxrb, or Lxra/b (1, 17, 20) show normal fetal development.
Mechanisms by which fetal and early postnatal environment influence lipid and glucose homeostasis in adult life are poorly defined. We previously showed that treatment of pregnant mice with the widely used LXR agonist T0901317 affects cholesterol metabolism in the fetus. T0901317 treatment of pregnant mice activated LXR in the fetuses, resulting in induction of genes involved in fetal cholesterol metabolism. Interestingly, the treatment did not profoundly influence cholesterol metabolism at adult age (26) . To delineate the functional importance of LXRs in control of fetal fatty acid and carbohydrate metabolism, we supplemented the diet of pregnant mice with T0901317. In the present study, we aimed to 1) determine whether pharmacological activation of Lxr in fetuses through maternal treatment with T0901317 activated Lxra or Lxrb in the fetal liver and influenced fetal fatty acid and glucose metabolism and 2) assess whether Lxr activation during fetal development changed lipid homeostasis into adulthood when mice were weaned onto standard chow or a high-fat diet. Our results indicate that maternal T0901317 treatment activates Lxrs and strongly affects lipid metabolism in the fetus. The prenatal treatment had only relatively minor, sex-selective effects on lipid homeostasis in (young) adulthood and did not influence the response to a short-term high-fat diet.
MATERIALS AND METHODS
Animals. Animals were housed in temperature-controlled rooms (23°C) with 12-h light cycling and received standard RMH-B mouse chow (Arie Blok, Woerden, The Netherlands) and water ad libitum. Pregnant C57BL/6J mice were obtained from Harlan (Horst, The Netherlands) at 2 days postcoitum (dpc). Lxra ϩ/Ϫ female mice (24) on a C57BL/6J background were crossed with Lxra ϩ/Ϫ male mice on the same background in our laboratory to obtain offspring with Lxra ϩ/ϩ , Lxra ϩ/Ϫ , and Lxra Ϫ/Ϫ genotypes, as described previously (26) . All experimental procedures were approved by the Ethics Committee for Animal Experiments of the University of Groningen.
Experimental procedures. From day 10 postcoitum until day 1 after delivery, C57BL/6J wild-type females received standard chow only or chow supplemented with 0.015% wt/wt T0901317 (Cayman Chemicals, Ann Arbor, Michigan), as described in Ref. 26 . On days 13.5, 15.5, 17.5, and 19.5 , postcoitum pregnant C57BL/6J mice were anesthetized with isoflurane and terminated by heart puncture. Lxra ϩ/Ϫ females received the T0901317 diet from day 10 postcoitum until day 19.5 postcoitum and were terminated on day 19.5 postcoitum. Blood was collected in EDTA-containing tubes. Liver samples of the dams were snap-frozen in liquid nitrogen. Fetuses were removed from uteri, their weight and length were measured, and they were terminated by decapitation and dissected. Pups were euthanized on day 1 postpartum. Blood samples were taken by exsanguination. Livers and intestines of fetuses and pups were collected, immediately snap-frozen in liquid nitrogen, and stored at Ϫ80°C until mRNA isolation or biochemical analysis. Samples for microscopic evaluation were snap-frozen in liquid nitrogen for Oil Red O staining. Pups were genotyped by PCR using allele-specific primers (wild-type: sense, 5Ј-CACCCATTCTCCCGTGCTTCTCTT G-3Ј; knockout: sense, 5Ј-GGGCCAGCTCATTCCTCCCACTCAT-3Ј; antisense for both, 5Ј-GTTTCTCTCCCCTATCTAGGGAGAC-3Ј).
To investigate lipogenesis and chain elongation of several fatty acids in the liver, a separate group of pregnant females on chow only or on chow with T0901317 received these diets with 10 mg/g [1-
13 C]acetate (Isotec, Miamisburg, OH) added from day 17.5 of gestation until day 19.5 postcoitum and were terminated on day 19.5 postcoitum.
To investigate the influence of receiving T0901317 during fetal development on coping with a high-fat/high-cholesterol diet at adult age, pregnant C57BL/6J females received chow only or chow supplemented with 0.015% wt/wt T0901317 from day 10 of gestation until day 1 after delivery. All dams received chow until the pups were weaned. Offspring received chow until 6 wk of age and received either chow or a semisynthetic Western-type diet (high fat/high cholesterol) containing 15% (wt/wt) cacao butter and 0.25% (wt/wt) cholesterol (Diet W; Special Diet Services, Witham, UK) for 2 wk. Offspring were terminated at 8 wk of age.
Analytical procedures. Liver homogenates were made by homogenization of the complete fetal liver (ϳ20 -80 mg, depending on age) in 200 l of ice-cold water. Hepatic lipids were extracted using the Bligh and Dyer method (4) . Pooled plasma samples from all animals of one group were used for lipoprotein separation by fast-protein liquid chromatography (FPLC), as described previously (27) . Commercially available kits were used for the determination of triglycerides in liver extracts, plasma samples, and FPLC fractions (Roche, Mannheim, Germany).
Determination of fatty acid synthesis using mass isotopomer distribution analysis. Mass isotopomer distribution analysis allows quantitation of the biosynthesis of polymers in vivo and is described in detail elsewhere (13) . Hepatic lipids from mothers and their fetuses receiving [1- 13 C]acetate were extracted and hydrolyzed by adding 0.5 ml of 0.5 M HCl in acetonitrile and heating for 45 min at 100°C. As an internal standard, 100 or 5 l of C17:0 (0.5 mg/ml) in chloroform was added to the mother and fetal liver extracts, respectively. Fatty acids were extracted by adding 1.5 ml of hexane, with 5 min of shaking and centrifugation for 5 min at 2,500 rpm. The organic phase was transferred to a clean tube, and samples were dried down at 40°C under N2. Samples were derivatized for 15 min at room temperature using 50 l of 1:2:6 pentafluorobenzyl-triethanolamine-acetonitrile solution; 0.5 ml of 0.1 M HCl was added, and the derivatives were extracted using 1 ml of hexane, with 5 min of shaking and 5 min of centrifugation at 2,500 rpm, after which the organic phase was transferred to a GC-MS vial. Enrichments of the PFB derivatives of hepatic fatty acids were measured by GC-MS. Derivatives were separated on a Zebron ZB-1 30 m ϫ 0.25 mm ID (0.25-m film thickness) capillary column (Phenomenex, Torrance, CA). The oven temperature was started at 100°C for 1 min, increased to 200°C at a rate of 50°C/min, then increased to 270°C at a rate of 5°C/min, and finally increased to 300°C at a rate of 50°C/min, and it remained at 300°C for 4 min. MS analysis was performed by electron capture negative ionization, with methane as a moderating gas. The ion monitored were m/z (mass-to-charge ratio) 255-259 corresponding to the m0 -m4 mass isotopomers for C16:0, m/z 269 -273 for C17:0, m/z 283-287 for C18:0, and m/z 281-285 for C18:19. Calculations on the newly synthesized polymers, the isotope enrichments of their monomer precursor (acetyl-CoA), and synthesis and chain elongation of stearic acid and oleic acid are described elsewhere (Ref. 21 and Oosterveer MH, unpublished observation).
RNA isolation and PCR procedures. Total RNA was extracted from frozen tissues with TriReagent (Sigma, St. Louis, MO) and quantified using a NanoDrop ND1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). cDNA synthesis and real-time quantitative PCR were performed as described by Plösch et al. (20) . Primer and probe sequences for 18S, Srebp1c, Acc1, Fasn, glucokinase (Gck), glucose-6-phosphatase (G6pc), phosphoenolpyruvate carboxykinase (Pck1), liver-specific pyruvate kinase (Pklr) (12) , Scd1 (24), Fxr, peroxisome proliferator-activated receptor-␣ (Ppara) (15) , Lxra, and Lxrb (26) have been published, with the exception of Rxra: sense 5Ј-GGCAAACATGGGGCTGAAC-3Ј, antisense 5Ј-GCTTGTCT-GCTGCTTGACAGAT-3Ј, and probe 5Ј-CCAGCTCACCAAAT-GACCCTGTTACCAAC -3Ј (accession no. NM_011305); and insulin receptor (Insr): sense 5Ј-TGAGTCAGCCAGTCTTCGAGAA-3Ј, antisense 5Ј-ACTACCAGCATTGGCTGTCCTT-3Ј, and probe 5Ј-CT-GCCATCATGTGGTCCGCCTTCT-3Ј (accession no. NM_010568). Expression levels were normalized to those of 18S ribosomal RNA. 18S rRNA was analyzed in separate runs and not found to be significantly different between the experimental groups.
Histology. Liver histology was examined on frozen liver sections after Oil Red O staining for neutral lipids using standard procedures.
Statistics. Statistical analyses were performed using SPSS 14.0 for Windows (SPSS, Chicago, IL). Differences between the groups were analyzed by Kruskal-Wallis test followed by Mann-Whitney U-test. Data presented are means Ϯ SD. A P value Ͻ0.05 was considered to be statistically significant.
RESULTS

T0901317 treatment to dams strongly induces genes involved in lipogenesis in dams and fetuses and acts mainly via
Lxra. As described previously, dams receiving T0901317 from 10.5 dpc to 19.5 dpc had slightly lower body weights on day 19.5 of gestation compared with control dams (26) . Liver weights of the treated dams, expressed as a percentage of total body weight, were increased by ϳ50% during the entire treatment period. Body weight of the fetuses on days 13.5, 15.5, and 17.5 postcoitum was not influenced by T0901317 administration; only on day 19.5 was it slightly reduced in the treated animals (26) (26) .
Our first aim was to establish whether T0901317 treatment of the wild-type dams affects gene expression levels of lipogenic Lxr target genes in dams and fetuses. In dams (Supplemental Fig. S1 , A-C; Supplemental Material for this article can be found on the AJP-Endocrinology and Metabolism web site) and in fetuses (Fig. 1, A-D) , administration of T0901317 strongly increased hepatic mRNA levels of Srebp1c, Fasn, and Scd1 compared with controls. Acc1 induction in the fetus was less pronounced by T0901317 treatment. Administration of T0901317 to pregnant mice did not significantly affect expression levels of nuclear receptors Rxra, Ppara, or Fxr in the fetal liver (Supplemental Fig. S2, A-C) .
To ascertain to what extent T0901317-induced effects on lipid metabolism were Lxr␣ or -␤ mediated, Lxra ϩ/Ϫ females were crossed with Lxra ϩ/Ϫ males. T0901317 treatment to the heterozygous dams resulted in significantly lower expression levels of lipogenic LXR target genes (Srepb-1c, Fasn) in the liver of Lxra-knockout fetuses than in wild-type fetuses (Fig. 2,  A and B) , indicating that the observed effects are, at least partly, mediated via an Lxr␣-specific effect.
T0901317 administration induces transient hepatic steatosis in pregnant mice and their fetuses. T0901317 treatment increased hepatic triglyceride content approximately fourfold in pregnant females after 3 days of treatment (Fig. 3A) . This effect gradually declined during gestation but was still apparent at the time of delivery. T0901317 treatment decreased plasma triglyceride concentrations in dams, but only during the pregnancy (Fig. 3B) . FPLC analysis of maternal plasma on day 19 of gestation revealed that the reduction in triglycerides in the T0901317-treated dams was mainly in VLDL-sized fractions (Fig. 3C) .
Maternal T0901317 treatment increased hepatic triglyceride concentrations in the fetuses (Fig. 4A) . However, on day 1 after delivery, triglyceride concentrations in livers of T091317-exposed pups remained at (induced) fetal level, whereas concentrations in control pups surged. Fetal plasma triglyceride concentrations, measurable at 19.5 dpc and on day 1 after delivery, were significantly elevated upon LXR activation (Fig.  4B) . Both in the control and in the T0901317-exposed pups, plasma lipid levels strongly increased after delivery. FPLC analysis showed a profile typical for fetal murine plasma and revealed that the increase in plasma triglyceride reflects elevated intermediate-density lipoprotein/LDL levels (Fig. 4C) . Consistent with gene expression data, in Lxra knockout fetuses, T0901317 administration increased hepatic triglyceride concentrations to a lower extent compared with wild-type fetuses (ϳ70 vs. ϳ150%, respectively, each P Ͻ 0.01; Fig.  4D de novo synthesis and chain elongation of oleate (C18:1) in dams and fetuses on day 19.5 of gestation (Fig. 6, A and B) but did not significantly alter palmitate (C16:0) or stearate (C18:0) synthesis. Chain elongation of stearate was reduced in treated fetuses. In dams, T0901317 administration increased the total hepatic pool of oleate, and it increased both the oleate and the palmitate pool in fetuses (Fig. 6, C and D) .
In utero Lxr activation does not influence basal insulin signaling. To test the hypothesis that Lxr activation influences carbohydrate metabolism in the wild-type mouse via induction of gene expression of Srebp1c and Chrebp and their subsequent target genes, we measured hepatic expression levels of several genes involved in carbohydrate metabolism in fetuses from untreated and treated wild-type dams. Treatment of dams with T0901317 had no influence on hepatic gene expression levels of G6pc, Pck1, Gck, Chrebp, Pklr, or Insr in the fetuses (Supplemental Fig. S3, A-F) . Since gene expression levels do not necessarily reflect physiological changes, we examined whether T0901317 treatment influenced insulin signaling in offspring. We performed an adapted insulin tolerance test in 1-day-old pups of treated and untreated dams. Intraperitoneal injection of 1-day-old pups with 0.75 U/kg insulin lowered blood glucose levels by 50% compared with pups injected with saline. Prenatal T0901317 treatment of the dams did not influence this insulin response compared with controls.
Long-term effects of prenatal Lxr activation in offspring into adulthood. We determined whether T0901317 treatment of the dam had long-lasting effects in the fetuses, i.e., into adulthood. Previous studies have indicated that a perinatal programming phenotype may only become apparent in adulthood upon exposure to a metabolic challenge. We administered T0901317 from day 10 of gestation until day 1 after delivery to C57BL/6J females via the diet (0.015% wt/wt in chow). Nest sizes were comparable in the two treatment groups, with an average of six pups per nest. After weaning, offspring received chow until 6 wk of age; subsequently, offspring received either chow or a semisynthetic Western-type diet (high fat/high cholesterol) containing 15% (wt/wt) cacao butter and 0.25% (wt/wt) cholesterol for 2 wk.
Body weight, liver weight, and liver weight to body weight were described previously (26) and were similar in all male and all female offspring. In chow-fed offspring, gene expression levels of Srebp1c, Fasn, and Scd1 were not different between pretreated and untreated male offspring on control diet (Fig. 7A) . However, control-fed females from T0901317-treated dams showed lower Fasn expression levels (Ϫ30%) compared with untreated females (Fig. 7B) . Male offspring on control diet from treated dams had ϳ42% higher hepatic triglyceride levels than male offspring on control diet from untreated dams, whereas female offspring on control diet from treated dams had ϳ42% lower hepatic triglyceride levels than female offspring on control diet from untreated dams ( Table 1) . Plasma triglycerides in males and females were not influenced by T0901317 pretreatment (Table 1) , although FPLC analysis showed that control male offspring receiving control diet had slightly higher VLDL levels than other male offspring groups (Fig.   7C ). No change in triglyceride FPLC profiles was seen between the different female offspring groups (Fig. 7D) .
The high-fat diet increased hepatic gene expression levels of the lipogenic LXR target genes Srebp1c and Scd1 in all male and female offspring regardless of exposure to T0901317 during gestation (Fig. 7, A and B) . Interestingly, a sex specificity was observed concerning Fasn expression. Fasn expression levels were significantly higher in high-fat male offspring from untreated dams compared with control-fed male offspring from untreated dams (ϩ200%, P ϭ 0.017), whereas Fasn expression levels were not upregulated by the high-fat diet in pretreated male offspring compared with pretreated control males (P ϭ 0.247). Similarly, females pretreated with T0901317 showed no upregulation of Fasn upon receiving the high-fat diet. In all male offspring, hepatic triglyceride levels were increased in animals that received the high-fat diet independently from pretreatment with T0901317 (Table 1 ). The high-fat diet did not lead to higher hepatic triglyceride levels in female offspring. Feeding the high-fat diet did not significantly change Values represent means Ϯ SD; n ϭ 6; *P Ͻ 0.05 for high fat vs. control; #P Ͻ 0.05 for T0901317 vs. control during gestation. MCC, male offspring from control dams on control diet; MCHF, male offspring from control dams on high-fat diet; MTC, male offspring of T0901317-treated dams on control diet; MTHF, male offspring of T0901317-treated dams on highfat diet; FCC, female offspring from control dams on control diet; FCHF, female offspring from control dams on high-fat diet; FTC, female offspring of T0901317-treated dams on control diet; FTHF, female offspring of T0901317-treated dams on high-fat diet. Data are means Ϯ SE. TG, triglyceride; CON, control; HFHC, high fat/high cholesterol. Parameters of C57BL/6J/OlaHsd offspring of mothers that received either chow only or chow supplemented with 0.015% T0901317. The offspring received either chow or a HFHC diet from 6 until 8 wk of age. Data are means Ϯ SD; n ϭ 6. *P Ͻ 0.05 HFHC vs. CON; †P Ͻ 0.05 T0901317 vs. CON.
plasma triglyceride levels or FPLC profiles in either males or females from chow-fed or T0901317-fed dams (Table 1 and Fig. 7 , B and C).
DISCUSSION
We previously showed that targeted treatment of pregnant mice with the synthetic LXR agonist T0901317 activates Lxr in the fetuses. In the present paper, we investigated whether in utero Lxr activation by T0901317 changes fatty acid and glucose metabolism in the fetus and in adult offspring. Our data show that this treatment results in acute effects on lipid homeostasis in dams and fetuses, but not on glucose homeostasis in fetuses, and in relatively minor but persistent consequences on fatty acid metabolism during adulthood.
Supplementation of the diet of the dam with T0901317 induced LXR target genes Srebp1c, Acc1, Fasn, and Scd1 in the fetal liver, suggesting that T0901317 transported across the placenta activates Lxr. We previously showed that maternal T0901317 administration did not influence fetal hepatic gene expression levels of Lxra or -b (26) . Our present results in Lxra-knockout fetuses show that hepatic Lxr effects are caused mainly by Lxra and that Lxrb compensates about 50% of Lxr action in the absence of Lxra.
Lxr-specific effects on lipid metabolism in the mother and in the fetus are comparable with the effects seen in nonpregnant adult mice (20, 23) . T0901317 administration increased hepatic triglyceride levels in dams, which was similar to studies in adult male mice (12, 14) . Hepatic triglyceride accumulation decreased during gestation in treated dams, possibly by increased transport from the liver, either to other tissues or to the rapidly growing fetus. The hepatic lipid concentrations in 1-day-old pups varied considerably within one group. Possibly, this is caused by the variation in feeding time of the pups. Prolonged fasting leads to hepatic lipid accumulation (25) . Because we could not control the breastfeeding times by the mother, some pups could have been fasted for a longer time than other pups, leading to higher liver triglyceride concentrations compared with pups that were fed prior to termination.
Grefhorst et al. (11) found no difference in plasma triglycerides in wild-type male mice treated with T0901317 compared with controls. T0901317-treated dams showed a lowering of plasma triglycerides compared with controls, representing a decrease in VLDL levels. Since plasma triglycerides in fetuses and pups from treated dams were increased, this seems to imply that treated dams transfer more lipid to the fetus compared with controls. Further studies have to elucidate how LXR activation influences lipid transport to the fetus.
Treated dams and fetuses showed an increase in absolute hepatic synthesis of oleic acid. Based on the [
13 C]acetate method used and the absence of increased palmitate and stearate synthesis, we interpreted that this observation is due to increased palmitate elongation and subsequent desaturation by Scd1. Scd1 catalyzes the synthesis of monounsaturated fatty acids from saturated fatty acids (10) . Scd1 is a target gene of Lxr, and its expression was increased in maternal and fetal liver upon T0901317 exposure.
Apart from the well-characterized role of Lxr in cholesterol metabolism, a potential role controlling glucose homeostasis via activation of Srebp1c and Chrebp has been suggested (9, 16), although this role remains controversial (8, 18) . Using an adapted insulin tolerance test in 1-day-old pups, no effect of the T0901317 pretreatment was found on glucose levels. Our results show that Lxr activation did not quantitatively influence the hepatic expression of any of the tested genes related to glucose metabolism in the fetus.
We next investigated whether Lxr activation by T0901317, which induced profound changes in lipid metabolism in perinatal life, also had long-lasting effects in lipid homeostasis, i.e., into adulthood. Female chow-fed offspring from T0901317-treated dams showed lower Fasn expression levels and lower hepatic triglyceride levels compared with untreated chow-fed female offspring. Strikingly, although no changes were seen on gene expression levels, in the male chow-fed offspring hepatic triglyceride levels were higher than in untreated chow-fed male offspring. Apparently, treatment with T0901317 in utero reduces hepatic storage of triglycerides in female offspring, whereas it induces hepatic storage of triglycerides in male offspring.
The subtle changes in adult lipid metabolism caused by in utero Lxr activation could be enlarged by receiving a high-fat diet at adult age. As expected (5), short-term (2 wk) high-fat feeding led to higher expression levels of lipogenic genes in all offspring and higher hepatic triglyceride levels in male offspring. However, these effects were present regardless of in utero treatment with T0901317. Apparently, receiving a highfat diet for 2 wk only eliminates rather than increases the sex-specific effects caused by in utero Lxr activation. On the basis of this observation, it is tempting to speculate that long-term high-fat feeding would possibly override the relatively small effects of the prenatal treatment.
We conclude that Lxr activation by T0901317 treatment of pregnant mice induces immediate effects on lipid metabolism in dams and fetuses, including increases in fatty acid synthesis and triglyceride levels. Lxr activation did not significantly influence expression of carbohydrate metabolism-related genes or the glucose response to insulin administration. Despite profound changes in lipid metabolism during fetal life, longterm effects on lipid metabolism appear to be rather mild and not related to the lipid response to a high-fat diet.
